# OnCo record curasight (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/curasight/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "curasight" ;
  schema:name "Curasight"@en ;
  schema:alternateName "Curasight A/S"@en ;
  schema:description "Curasight is a Danish company developing a PET scan tracer and a matching radioactive treatment that both target uPAR, a protein found on aggressive cancers. The scan is being tested to judge how aggressive early prostate cancer is, and the treatment is in a first trial in brain tumours."@en ;
  schema:url <https://onco.cc/companies/curasight/>, <https://curasight.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://curasight.com/>, <https://curasight.com/about-us/history/> ;
  schema:addressCountry "DK" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-low-risk/>, <https://onco.cc/cancers/glioblastoma/> ;
  onco:sections <https://onco.cc/fronts/radiopharma/>, <https://onco.cc/fronts/imaging/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/>, <https://onco.cc/technologies/pet/> ;
  onco:trials <https://onco.cc/trials/nct06474806/> .